Effect of green tea extract/poly-γ-glutamic acid complex in obese type 2 diabetic mice

Diabetes and Metabolism Journal

Volumn 37, Issue 3, 2013, Pages 196-206

  Bae, Ki Cheor ^a   Park, Jae Hyung ^a   Na, Ann Yae ^a   Kim, Sun Joo ^a   Ahn, Shinbyoung ^b   Kim, Sang Pyo ^a   Oh, Byung Chul ^c   Cho, Ho Chan ^a   Kim, Yong Woon ^d   Song, Dae Kyu ^a  

^a Keimyung University School of Medicine   (South Korea)

^b GCB Co Ltd   (South Korea)

^c Gachon University   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

Author keywords

db db mice; Diabetes mellitus, type 2; Gallated catechins; Glucose intolerance; Obesity; Poly glutamic acid

Indexed keywords

EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; POLYGLUTAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPETITE; ARTICLE; BODY FAT; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY LIVER; FOOD INTAKE; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; INTESTINE ABSORPTION; MONOTHERAPY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; ORGAN SIZE; PANCREAS ISLET; THERAPY EFFECT; TREATMENT DURATION; WEIGHT GAIN;

EID: 84879491024     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2013.37.3.196     Document Type: Article

References (30)

1. Rossner S. Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 2002;26 Suppl 4:S2-4.
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
3. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-72.
4. Perley M, Kipnis DM. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 1966;15:867-74.
5. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988;81:442-8.
6. Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-58.
7. Park JH, Jin JY, Baek WK, Park SH, Sung HY, Kim YK, Lee J, Song DK. Ambivalent role of gallated catechins in glucose tolerance in humans: a novel insight into non-absorbable gallated catechin-derived inhibitors of glucose absorption. J Physiol Pharmacol 2009;60:101-9.
8. Kobayashi Y, Suzuki M, Satsu H, Arai S, Hara Y, Suzuki K, Miyamoto Y, Shimizu M. Green tea polyphenols inhibit the sodium- dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem 2000;48: 5618-23.
9. Mabe K, Yamada M, Oguni I, Takahashi T. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents Chemother 1999;43:1788-91.
10. Takabayashi F, Harada N, Yamada M, Murohisa B, Oguni I. Inhibitory effect of green tea catechins in combination with sucralfate on Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol 2004;39:61-3.
11. Hu R, He C, Liu J, Wu Y, Li J, Feng Z, Huang J, Xi XG, Wu Z. Effects of insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex on diabetic rat model. J Pharm Sci 2010;99:3041-7.
12. Karmaker S, Saha TK, Yoshikawa Y, Sakurai H. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice. Macromol Biosci 2009;9:279-86.
13. Karmaker S, Saha TK, Yoshikawa Y, Sakurai H. Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly (gamma-glutamic acid) oxovanadium (IV) complex. ChemMedChem 2007;2:1607-12.
14. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404:661-71.
15. Harrold JA. Hypothalamic control of energy balance. Curr Drug Targets 2004;5:207-19.
16. Johnston K, Sharp P, Clifford M, Morgan L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett 2005;579:1653-7.
17. Van Amelsvoort JM, Van Hof KH, Mathot JN, Mulder TP, Wiersma A, Tijburg LB. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica 2001; 31:891-901.
18. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum pro teomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 2004;4:18.
19. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000;141:980-7.
20. Naftalin RJ, Afzal I, Cunningham P, Halai M, Ross C, Salleh N, Milligan SR. Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. Br J Pharmacol 2003;140:487-99.
21. Kim W, Choi K, Kim Y, Park H, Choi J, Lee Y, Oh H, Kwon I, Lee S. Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from Chungkook-Jang. Appl Environ Microbiol 1996;62:2482-8.
22. Kwak CS, Lee MS, Park SC. Higher antioxidant properties of Chungkookjang, a fermented soybean paste, may be due to increased aglycone and malonylglycoside isoflavone during fermentation. Nutr Res 2007;27:719-27.
23. Kwon DY, Jang JS, Lee JE, Kim YS, Shin DH, Park S. The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator-activated receptor-gamma activity in vitro. Biofactors 2006;26:245-58.
24. Kwon DY, Jang JS, Hong SM, Lee JE, Sung SR, Park HR, Park S. Long-term consumption of fermented soybean-derived Chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rats. Eur J Nutr 2007;46:44-52.
25. Sung MH, Park C, Kim CJ, Poo H, Soda K, Ashiuchi M. Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications. Chem Rec 2005;5:352-66.
26. Park JH, Choi JC, Sung MH, Kang JH, Chang MJ. High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans. J Microbiol Biotechnol 2011;21:766-75.
27. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003;107:2072-5.
28. Lee H, Chang MJ, Kim SH. Effects of poly-gamma-glutamic acid on serum and brain concentrations of glutamate and GABA in diet-induced obese rats. Nutr Res Pract 2010;4:23-9.
29. Negishi M, Shimomura K, Proks P, Shimomura Y, Mori M. Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in type 2 diabetic patients. Br J Clin Pharmacol 2008;66:318-9.
30. Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003;14:326-32.